Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22021620 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients
Condition: HIV Infections
Intervention: Drug: raltegravir

Study has passed its completion date and status has not been verified in more than two years.